Overexpressed transcription factor FOXM1 contributes to the progression of colorectal cancer.

作者: HONGMEI ZHANG , HUA ZHONG , LEI LI , WANSHENG JI , XIAOQIAN ZHANG

DOI: 10.3892/MMR.2016.4875

关键词: Molecular medicineCancer researchMolecular biologyFOXM1Cell cultureCell cycleOncogeneBiologyCancerColorectal cancerImmunohistochemistry

摘要: Forkhead box M1 (FOXM1) is a characteristic proliferation‑associated transcription factor, which overexpressed in various types of human cancer. The aim the present study was to determine expression FOXM1 large collection colorectal cancer (CRC) samples. Between March 2012 and January 2014, 96 patients with histologically diagnosed CRC were recruited into current study. Using immunohistochemistry, reverse transcription‑quantitative polymerase chain reaction western blotting, mRNA protein levels tissue samples determined. function cells evaluated by small interfering RNA‑mediated depletion FOXM1, followed analyses cell proliferation invasion. High staining for observed significantly more samples: 85.42% (82/96) compared 18.75% (18/96) adjacent normal mucosa Silencing inhibited LoVo cells, express relatively high level invasion migration also markedly suppressed. data from suggested that pathogenesis may be mediated inhibition provide promising therapeutic strategy CRC.

参考文章(26)
Guanzhen Yu, Aidong Zhou, Jianfei Xue, Chen Huang, Xia Zhang, Shin-Hyuk Kang, Wen-Tai Chiu, Christina Tan, Keping Xie, Jiejun Wang, Suyun Huang, None, FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway Oncotarget. ,vol. 6, pp. 11281- 11294 ,(2015) , 10.18632/ONCOTARGET.3596
Molly Perencevich, Elena M. Stoffel, A multidisciplinary approach to the diagnosis and management of multiple colorectal polyps. Gastroenterología y Hepatología. ,vol. 7, pp. 420- 423 ,(2011)
Guo-Qing Chen, Cheng-Fang Tang, Xiao-Ke Shi, Cheng-Yuan Lin, Sarwat Fatima, Xiao-Hua Pan, Da-Jian Yang, Ge Zhang, Ai-Ping Lu, Shu-Hai Lin, Zhao-Xiang Bian, Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism Oncotarget. ,vol. 6, pp. 24148- 24162 ,(2015) , 10.18632/ONCOTARGET.4376
Jaudah Al-Maghrabi, Eman Emam, Wafaey Gomaa, Moaath Saggaf, Abdelbaset Buhmeida, Mohammad Al-Qahtani, Mahmoud Al-Ahwal, c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence BMC Cancer. ,vol. 15, pp. 676- 676 ,(2015) , 10.1186/S12885-015-1662-6
FRANCESCA CONSOLARO, GIUSEPPE BASSO, SADAF GHAEM-MAGAMI, ERIC W.-F. LAM, GIAMPIETRO VIOLA, FOXM1 is overexpressed in B-acute lymphoblastic leukemia (B-ALL) and its inhibition sensitizes B-ALL cells to chemotherapeutic drugs International Journal of Oncology. ,vol. 47, pp. 1230- 1240 ,(2015) , 10.3892/IJO.2015.3139
Pradip Raychaudhuri, Hyun Jung Park, FoxM1: A Master Regulator of Tumor Metastasis Cancer Research. ,vol. 71, pp. 4329- 4333 ,(2011) , 10.1158/0008-5472.CAN-11-0640
Tanya V. Kalin, Vladimir Ustiyan, Vladimir V. Kalinichenko, Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle. ,vol. 10, pp. 396- 405 ,(2011) , 10.4161/CC.10.3.14709
David Balli, Yufang Zhang, Jonathan Snyder, Vladimir V. Kalinichenko, Tanya V. Kalin, Endothelial Cell–Specific Deletion of Transcription Factor FoxM1 Increases Urethane-Induced Lung Carcinogenesis Cancer Research. ,vol. 71, pp. 40- 50 ,(2011) , 10.1158/0008-5472.CAN-10-2004
Brenda K. Shelton, Introduction to colorectal cancer Seminars in Oncology Nursing. ,vol. 18, pp. 2- 12 ,(2002) , 10.1053/SONU.2002.33074